Todd Asset Management LLC lowered its stake in shares of CVS Health Corp (NYSE:CVS) by 1.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 206,280 shares of the pharmacy operator’s stock after selling 3,525 shares during the quarter. Todd Asset Management LLC’s holdings in CVS Health were worth $16,774,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CVS. Horan Capital Advisors LLC. grew its position in CVS Health by 3.2% in the 2nd quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock valued at $2,584,000 after acquiring an additional 1,000 shares during the last quarter. Community Bank N.A. grew its position in CVS Health by 7.3% in the 2nd quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock valued at $1,608,000 after acquiring an additional 1,362 shares during the last quarter. FIL Ltd grew its position in CVS Health by 13.8% in the 2nd quarter. FIL Ltd now owns 514,836 shares of the pharmacy operator’s stock valued at $41,424,000 after acquiring an additional 62,318 shares during the last quarter. Midwest Investment Management LLC grew its position in CVS Health by 6.2% in the 2nd quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock valued at $1,720,000 after acquiring an additional 1,245 shares during the last quarter. Finally, ETRADE Capital Management LLC grew its position in CVS Health by 3.7% in the 2nd quarter. ETRADE Capital Management LLC now owns 55,653 shares of the pharmacy operator’s stock valued at $4,478,000 after acquiring an additional 1,979 shares during the last quarter. 81.69% of the stock is currently owned by hedge funds and other institutional investors.

Shares of CVS Health Corp (NYSE:CVS) opened at $78.78 on Tuesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. The firm has a market capitalization of $79,803.51, a price-to-earnings ratio of 16.28, a P/E/G ratio of 1.25 and a beta of 0.90. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.72.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.01. The firm had revenue of $46.18 billion during the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The firm’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.64 EPS. analysts anticipate that CVS Health Corp will post 5.89 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 2nd. Investors of record on Wednesday, January 24th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.54%. The ex-dividend date is Tuesday, January 23rd. CVS Health’s dividend payout ratio (DPR) is currently 41.32%.

CVS has been the topic of several research analyst reports. Jefferies Group set a $76.00 price objective on CVS Health and gave the company a “hold” rating in a research report on Monday, December 4th. Royal Bank of Canada initiated coverage on CVS Health in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price objective on the stock. Vetr downgraded CVS Health from a “buy” rating to a “hold” rating and set a $77.11 price objective on the stock. in a research report on Thursday, January 4th. Robert W. Baird reaffirmed a “hold” rating and issued a $77.00 price objective on shares of CVS Health in a research report on Friday, October 27th. Finally, UBS Group raised CVS Health from an “outperform” rating to a “strong-buy” rating in a research report on Thursday, January 4th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $86.66.

In related news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the sale, the executive vice president now directly owns 15,556 shares in the company, valued at approximately $1,166,700. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.61% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Todd Asset Management LLC Has $16.77 Million Stake in CVS Health Corp (CVS)” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2018/01/16/todd-asset-management-llc-has-16-77-million-stake-in-cvs-health-corp-cvs.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related stocks with our FREE daily email newsletter.